Vitamin D improves symptoms of severe eczema in kids, finds study Dr. Kamal Kant Kohli4 Nov 2020 10:30 AM ISTResearchers have found in a randomized controlled trial that Vitamin D supplementation eased the symptoms experienced by children with severe atopic...
Probiotic skin therapy improves atopic dermatitis in children, NIH study suggests Dr. Kamal Kant Kohli10 Sept 2020 4:45 PM ISTAtopic dermatitis is a chronic inflammatory skin disease characterized by dry, itchy skin and rashes. The disease is most common in children and the...
Topical calcineurin inhibitors safe in atopic dermatitis, don't raise cancer risk: JAMA Dr Satabdi Saha24 Aug 2020 11:15 AM ISTA recent study has suggested that Atopic Dermatitis has no association with exposure to Topical calcineurin inhibitors(TCI ). The research further...
Upadacitinib Plus topical steroids Improve symptoms in Atopic Dermatitis: Phase 3 Study Hina Zahid3 Aug 2020 6:30 PM ISTNORTH CHICAGO -- AbbVie (NYSE: ABBV) today announced upadacitinib (15 mg and 30 mg, once daily) plus topical corticosteroids (TCS) met the co-primary...
S. aureus infection increases risk of atopic dermatitis in infants Medha Baranwal22 July 2020 7:00 PM ISTJapan: Cheek skin colonized by Staphylococcus aureus is associated with the early development of developing atopic dermatitis in infants,...
Subcutaneous nemolizumab improves itching in atopic dermatitis patients: NEJM Medha Baranwal19 July 2020 9:00 PM ISTJapan: Subcutaneous nemolizumab plus topical agents versus placebo plus topical agents helps in a greater reduction of itching in patients...
Atopic Dermatitis: Dupilumab gets FDA approval for pediatric patients Medha Baranwal25 Jun 2020 7:52 PM ISTUSA: Dupixent (dupilumab) has received another approval from the US Foood and Drug Administration (FDA) to be used in children aged 6 to 11 years...
Sanofi-Regeneron Dupixent gets NMPA nod to treat atopic dermatitis Ruchika Sharma22 Jun 2020 10:30 AM ISTThe approval was based on positive data from the global LIBERTY AD clinical trial program that included nearly 3,000 patients with inadequately...
Pfizer Abrocitinib hits mark in phase 3 of Atopic Dermatitis trial Ruchika Sharma14 Jun 2020 9:45 AM ISTAbrocitinib received Breakthrough Therapy designation from the FDA for the treatment of patients with moderate to severe AD in February 2018, Pfizer...
SPARC, Sun Pharma enter into license agreement for SCD-044, a potential treatment for atopic dermatitis, psoriasis, more Ruchika Sharma29 May 2020 4:25 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. and Sun Pharmaceutical Industries Ltd. have announced a worldwide licensing agreement on the...
Dupilumab improves severe Atopic Dermatitis in children between 6 to 11 years: Phase 3 Data Dr. Kamal Kant Kohli6 April 2020 10:30 PM ISTTARRYTOWN, N.Y. and PARIS/ --Patients who added Dupixent to topical corticosteroids improved skin clearance; average overall disease improved by...
Study links maternal depression to atopic dermatitis in children Dr. Kamal Kant Kohli22 Jan 2020 10:00 AM ISTWASHINGTON: Maternal depression in the postpartum period, and even beyond, is associated with the development of atopic dermatitis (AD)...
